{
  "id": "80e7e9ae-ffda-4d2d-a5c8-54322723851a",
  "title": "Half the world population could be diabetic or insulin resistant by 2050",
  "link": "https://fortune.com/2025/05/26/half-the-world-population-potentially-diabetic-or-insulin-resistant-by-2050/",
  "description": "Artificial intelligence will play an increasingly important role in preventing and treating diseases related to diabetes, especially in regions with large diabetic populations like the Middle East.",
  "author": "Ian Mount",
  "published": "Mon, 26 May 2025 13:30:46 +0000",
  "source": "https://fortune.com/feed",
  "categories": [
    "Health"
  ],
  "byline": "Ian Mount",
  "length": 238,
  "excerpt": "Artificial intelligence will play an increasingly important role in preventing and treating diseases related to diabetes, especially in regions with large diabetic populations like the Middle East.",
  "siteName": "Fortune",
  "favicon": "",
  "text": "Olfat Berro, Area Head, Middle East, Roche Pharmaceuticals; Leah Cotterill, CEO for the Middle East and Africa (outside KSA), Cigna Healthcare; and Noosheen Hashemi, founder and CEO, January AI. (from left to right)Iman Al-dabbagh—Fortune",
  "image": "https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?resize=1200,600",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-cy=\"article-wrapper\" id=\"content\" role=\"article\"\u003e\u003cp\u003e\u003cimg alt=\"Olfat Berro, Area Head, Middle East, Roche Pharmaceuticals; Leah Cotterill, CEO for the Middle East and Africa (outside KSA), Cigna Healthcare; and Noosheen Hashemi, founder and CEO, January AI. (from left to right)\" data-content-placement=\"primary_image\" fetchpriority=\"high\" loading=\"eager\" width=\"768\" height=\"512\" decoding=\"async\" data-nimg=\"1\" sizes=\"(max-width: 500px) 60vw, (max-width: 768px) 80vw, (max-width: 1200px) 33vw, 20vw\" srcset=\"https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=64\u0026amp;q=75 64w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=96\u0026amp;q=75 96w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=128\u0026amp;q=75 128w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=256\u0026amp;q=75 256w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=320\u0026amp;q=75 320w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=384\u0026amp;q=75 384w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=480\u0026amp;q=75 480w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=576\u0026amp;q=75 576w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=768\u0026amp;q=75 768w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=1024\u0026amp;q=75 1024w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=1280\u0026amp;q=75 1280w, https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=1440\u0026amp;q=75 1440w\" src=\"https://fortune.com/img-assets/wp-content/uploads/2025/05/54535010968_e206942786_o-e1748261133848.jpg?w=1440\u0026amp;q=75\"/\u003e\u003c/p\u003e\u003cp\u003eOlfat Berro, Area Head, Middle East, Roche Pharmaceuticals; Leah Cotterill, CEO for the Middle East and Africa (outside KSA), Cigna Healthcare; and Noosheen Hashemi, founder and CEO, January AI. (from left to right)\u003c/p\u003e\u003cp\u003eIman Al-dabbagh—Fortune\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": null,
  "modifiedTime": null
}
